


Demonstration of causality of pollen in hay fever (Blackley)
1873
Definition of anaphylaxis
1902
First case reports on anaphylactic reactions induced by food "the alimentary anaphylaxis"
1908
Start of allergen immunotherapy (AIT)
1911
1911
Discovery of histamine by Henry Dale
1919
Demonstration that allergy can be transferred by blood
1921
Prausnitz - Küstner test
Coining the term "patch test"
1931
Decade 1950 - 1960
Adrenocorticotropic hormone (ACTH) is beneficial in the treatment of inflammatory diseases (Note: in 1949 it was described its role on rheumatoid arthritis and in 1950 in other inflammatory diseases)
1949
1955
First polio vaccine
1955
Basophils are main source of histamine among blood cells
1956 EAACI is founded in Florence
Immune complexes are described
1958
Decade 1960 - 1970
1960
Identification of allergen molecules
Histamine release
1964
1965
X-ray based structure of Gal d 4 - egg white lysozyme
Decade 1970 - 1980
Description of the function of B cells
1971
1972
Identification of histamine receptor H2R
1973
Dendritic cells
Patent on FACS
1976
Decade 1980 - 1990
IUIS/WHO allergen Standardisation Committe by Alain de Weck and IUIS/WHO nomenclature subcommittee
1980
1984
IgE Receptor
New adjuvant of calcium phosphate for allergen vaccine - patent Institute Pasteur Paris France
Th1/Th2 concept
1987
PCR
1987
1988
IL4
Recombinant Allergens
1989
Decade 1990 - 2000
1992
Allergy - official journal of EAACI
1996
Toll like receptors
IL 10 / IgG4 and their role in IT
T regulatory cells
PAI – official journal of EAACI
1991, 1999 and 2000
Cloning of the Histamine receptors H1R, H2R, H3R and H4R
Decade 2000 - 2010
AIT trials with hypoallergens, peptides
2000
2002
ARIA guidelines recommends AIT as effective and long term effective treatment
Sublingual AIT complements SCIT
2003
EU Food Allergen labelling legislation
AIT induces blocking antibodies
Quality of life of allergic patients
2003
2005
First trials on AIT with recombinant allergen material
Prevention of allergy - clinical trials
2007
2008
EMA guidelines for AIT product and clinical documentation
Decade 2011 - 2020
Successful anti IL-5 and anti IL-4/IL-13 phase III trials in asthma and atopic dermatitis
EU Parliament IG on Allergy and Asthma
Number of EAACI members reaches 9,000
2015
